Skip to Content
Merck
  • A novel highly specific and potent inhibitor of calmodulin-dependent protein kinase II.

A novel highly specific and potent inhibitor of calmodulin-dependent protein kinase II.

Biochemical and biophysical research communications (1995-07-26)
A Ishida, I Kameshita, S Okuno, T Kitani, H Fujisawa
ABSTRACT

A novel synthetic peptide AIP (autocamtide-2-related inhibitory peptide), a nonphosphorylatable analog of autocamtide-2, was found to be a highly specific and potent inhibitor of calmodulin-dependent protein kinase II (CaM-kinase II). It was 50 and 500 times more potent than CaMK-(281-302Ala286) and KN-93, respectively, under the assay conditions used. The inhibition was unaffected by the presence or absence of Ca2+/calmodulin, and it was competitive with autocamtide-2 and noncompetitive with syntide-2. AIP (1 microM) completely inhibited CaM-kinase II activity, but did not affect cyclic AMP-dependent protein kinase, protein kinase C, calmodulin-dependent protein kinase IV, and unidentified protein kinases occurring in a rat brain extract. These results indicate that AIP is a useful tool for studying the physiological roles of CaM-kinase II.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Autocamtide 2-related inhibitory peptide, ≥97% (HPLC), lyophilized powder